ReviewDrug, healthcare and patient safety2023

Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease.

Shaun O'Hagan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.